Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China

被引：0
|
作者：
Huang, Kun [1 ]
Liu, Guoqing [1 ]
Wu, Runhui [1 ]
Chen, Zhenping [1 ]
Zhen, Yingzi [1 ]
Wu, Xinyi [1 ]
机构：
[1] Beijing Childrens Hosp, Beijing, Peoples R China
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
emicizumab; FVIII inhibitor; haemophilia A;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FP-09.02 (
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making
    Mason, Jane A.
    Young, Guy
    HAEMOPHILIA, 2021, 27 (05) : 724 - 729
  • [42] Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring
    Barg, Assaf A.
    Budnik, Ivan
    Avishai, Einat
    Brutman-Barazani, Tami
    Bashari, Dalia
    Misgav, Mudi
    Lubetsky, Aaron
    Kuperman, Amir A.
    Livnat, Tami
    Kenet, Gili
    HAEMOPHILIA, 2021, 27 (03) : 383 - 391
  • [43] A REAL-WORLD EXPERIENCE WITH EFGARTIGIMOD IN GENERALIZED MYASTHENIA GRAVIS IN CHINA
    Chen, Yuping
    Wang, Yan
    Tao, Xiaoyong
    Yang, Yanhua
    Xu, Shengjie
    Qiu, Feng
    MUSCLE & NERVE, 2024, 70 (03) : 520 - 520
  • [44] Emicizumab treatment and monitoring in a paediatric cohort: real-world data
    Barg, Assaf A.
    Livnat, Tami
    Budnik, Ivan
    Avishai, Einat
    Brutman-Barazani, Tami
    Tamarin, Ilia
    Bashari, Dalia
    Misgav, Mudi
    Kenet, Gili
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : 282 - 290
  • [45] AN OVERVIEW OF REAL-WORLD DATA SOURCES FOR REAL-WORLD STUDIES IN ONCOLOGY AND RARE DISEASES IN CHINA
    Jia, Y.
    Zhan, S.
    Guo, J. J.
    Cao, X.
    Zhang, Y. J.
    VALUE IN HEALTH, 2023, 26 (06) : S392 - S392
  • [46] Safety and effectiveness of baloxavir marboxil and oseltamivir for influenza in children: a real-world retrospective study in China
    Ge, Xilin
    Chen, Yang
    Wu, Wei
    Lu, Jinmiao
    Wang, Yi
    Li, Zhiping
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [47] REAL-WORLD EVIDENCE ON ECONOMIC BURDEN OF MULTIPLE MYELOMA IN CHINA: A RETROSPECTIVE STUDY OF CLAIMS DATA
    Wang, J.
    Zhang, X.
    Liu, S.
    Sun, R.
    Liu, J.
    VALUE IN HEALTH, 2020, 23 : S51 - S51
  • [48] Prophylaxis with emicizumab in 50 children and adolescents with severe haemophilia A without inhibitor in Uruguay: National experience
    Lemos, Felipe
    Petraccia, Carlos
    Laura Fraga, Maria
    Gomez, Rosario
    Lutz, Stefani
    Laura Casuriaga, Ana
    Inguanzo, Marianella
    Gonzalez, Jimena
    Echeverria, Silvina
    Gomez, Florencia
    Arocena, Maria
    Gonzalez, Yenirellys
    Giachetto, Gustavo
    Boggia, Beatriz
    HAEMOPHILIA, 2024, 30 : 96 - 97
  • [49] Bleeding episodes and surgical procedures in children and adults with haemophilia A on prophylaxis with emicizumab - The experience of a Portuguese centre
    Catarina Camara, Cristina Catarino
    Felix, Jorge
    Pires, Filipa
    Pereira, Artur
    Rodrigues, Fatima
    Cabecinha, Raquel
    Afonso, Patricia
    Rocha, Elsa
    HAEMOPHILIA, 2024, 30 : 143 - 148
  • [50] Patients with haemophilia A with inhibitors in China: a national real-world analysis and follow-up
    Dou, Xueqing
    Liu, Wei
    Poon, Man-Chiu
    Zhang, Xinsheng
    Wu, Jingsheng
    Zeng, Xiaojing
    Wu, Runhui
    Hu, Qun
    Li, Chengping
    Wang, Xiaomin
    Song, Xuewen
    Chen, Lingling
    Zhang, Lei
    Xue, Feng
    Yang, Renchi
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) : 900 - 908
12345